research and technological development
ORGANOIDS AND ORGAN-ON-CHIP
Advanced 3D in vitro models that mimic the structure and function of a human organ emerge as promising tools for drug discovery, disease modeling and personalised medicine, by replacing animal testing. GATE wants to bring these high-throughput screening tools closer to biotechnology, pharmaceutical, cosmetics and chemical companies.
Gene therapy seeks to modify or introduce genes into a patient for treating, preventing or curing disease. U(Z)Gent develops gene therapy for epilepsy, hereditary blindness and deafness.
Tissue engineering exploits the power of materials and bioactive molecules to guide stem cell behavior and construct living tissues and organs for repair therapies. U(Z)Gent applies tissue engineering principles for wound dressings, implantable stents, designing a meniscus, or, for example, to develop an adipose-based tissue therapy for breast reconstruction or osteoarthritis.
Cell therapy is an emerging technology based on delivering cells as medicines. U(Z)Gent develops clinical stage cell therapies for diseases such as cancer, cardiac and infectious diseases.